Patents by Inventor Helene Depui

Helene Depui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Patent number: 8114435
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: February 14, 2012
    Assignee: AstraZeneca AB
    Inventors: Helene Depui, Per Lundberg
  • Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID
    Publication number: 20090297594
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Application
    Filed: February 9, 2009
    Publication date: December 3, 2009
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Patent number: 7488497
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: February 10, 2009
    Assignee: AstraZeneca AB
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Publication number: 20040022846
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred.
    Type: Application
    Filed: July 14, 2003
    Publication date: February 5, 2004
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Patent number: 6613354
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: September 2, 2003
    Assignee: AstraZeneca AB
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Publication number: 20020155153
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Application
    Filed: March 4, 2002
    Publication date: October 24, 2002
    Applicant: AstraZeneca AB.
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
    Patent number: 6365184
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: April 2, 2002
    Assignee: AstraZeneca AB
    Inventors: Helene Depui, Per Lundberg
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
    Patent number: 6183776
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more antacid agents or an alginate in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer and an optional separating layer in between the proton pump inhibitor and the enteric coating. The fixed formulation is in the form of multilayered tablets, sachets or multiple unit tableted dosage forms. The multiple unit dosage form is most preferred. The new fixed formulation is especially useful in the treatment of disorders associated with dyspepsia such as heartburn.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: February 6, 2001
    Assignee: Astra Aktiebolag
    Inventors: Helene Depui, Agneta Hallgren
  • Oral pharmaceutical dosage form
    Patent number: 6136344
    Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more antibacterial compounds in a fixed formulation. The fixed formulation is intended for oral use and in the form of an enteric coating layered tablet, an capsule or a multiple unit tableted dosage form. The multiple unit dosage form is most preferred. The new fixed formulation is especially useful in the treatment of disorders associated with Helicobacter infections.
    Type: Grant
    Filed: April 15, 1996
    Date of Patent: October 24, 2000
    Assignee: Astra Aktiebolag
    Inventors: Helene Depui, Adam Rosinski
  • Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
    Patent number: 6132771
    Abstract: An oral pharmaceutical dosage form comprising a proton pump inhibitor and one or more prokinetic agents in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of multilayered tablets, capsules or multiple unit tableted dosage forms. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of disorders associated with gastro oesophageal reflux diseases.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: October 17, 2000
    Assignee: AstraZeneca AB
    Inventors: Helene Depui, Agneta Hallgren